Moderna, Inc.·4

Feb 13, 4:33 PM ET

Hoge Stephen 4

Research Summary

AI-generated summary

Updated

Moderna (MRNA) President Stephen Hoge Receives Award; 2,362 Shares Withheld

What Happened

  • Stephen Hoge, President of Moderna, reported the vesting of 4,884 performance-based restricted stock units (PSUs) on 2026-02-11.
  • To cover tax withholding, 2,362 of those shares were withheld (reported as a disposition) at $41.99 per share, totaling about $99,180. Net shares delivered to Hoge after withholding equal 2,522 shares (4,884 vested − 2,362 withheld).
  • This was an award/vesting event, not an open-market purchase or sale — withholding for taxes is a routine administrative action.

Key Details

  • Transaction date: 2026-02-11; Filing date: 2026-02-13 (filed within the normal 2-business-day window).
  • Award: 4,884 shares (PSUs) reported as an acquisition at $0.00 (vesting).
  • Withholding/tax payment: 2,362 shares reported disposed at $41.99/share = $99,180.
  • Net shares received from vesting: 2,522 shares.
  • Ownership after transaction: not specified in the provided filing details.
  • Footnotes: F1 — Vesting of PSUs granted Feb 28, 2023; F2 — Withheld shares elected to satisfy tax withholding; F3 — Some shares are held directly by a trust for Hoge’s spouse and children (he disclaims beneficial ownership of those trust-held shares except for any pecuniary interest).

Context

  • PSUs vesting and share-withholding for taxes are common and administrative; they do not necessarily indicate a change in insider sentiment.
  • Withholding is functionally similar to a cashless transaction (shares retained to cover taxes) rather than an open-market sale.
  • The trust ownership and Section 16 disclaimer mean certain shares reported may be held for family benefit and are not necessarily under Hoge’s direct control.